Thanks Jim, and good afternoon. Today the company filed its form 10-Q for the quarter ended March 31, 2020 with the securities and exchange commission. As always, I recommend you read this filing in its entirety. Before we get into the details for the quarter, I would like to make a few comments regarding the COVID-19 pandemic impacts. The COVID-19 pandemic did not have a material impact on our first quarter sales. However, sales volumes in the second quarter of 2020 are expected to be negatively impacted, and collections of accounts receivable are expected to slow, based on the impacts we have seen to-date in collections. The company has been able to maintain our operations to serve our customers, but this may change in the future as government and other responses to COVID-19 evolve. We've worked closely with government officials in the jurisdictions, where we operate to keep manufacturing facilities open during the pandemic. Kodak has endeavored to address the recommended actions of government and health authorities to protect employees worldwide, with particular measures in place for those working in plants and distribution facilities. We intend to continue to work with government authorities and implement employee safety measures, so the manufacturing and distribution of products during the pandemic can continue. However, uncertainty resulting from the pandemic could result in an unforeseen disruption to Kodak's operations or supply chain. As such, we are reducing operating costs for the use of temporary furloughs and pay reductions for employees, as well as the deferral of spend. Our operations are negatively impacted by the COVID-19 pandemic. Additionally, late in the first quarter, governments across the world began to respond to the COVID-19 pandemic, with the introduction of economic relief programs. The vast majority of government relief packages are geared toward individuals, small businesses or to the healthcare industry. Kodak has implemented the government relief under which we are eligible. These are primarily in the areas of tax deferrals and job retention assistance. The government relief had very little impact on the first quarter, as most programs were not operational until the second quarter. Employee retention related relief is available to Kodak in some countries which includes, job retention, wage subsidies, social benefits relief and payroll tax relief. Non-HR related tax relief is also only available to Kodak in some countries, which is mainly comprised of deferral of various tax payments. Kodak is ineligible for most government subsidized loan programs. We are continuing to explore eligibility and jurisdictions such as the U.S., England and Germany. As the duration and scope of COVID-19 continues to evolve, Kodak will continue to monitor for any new government relief programs, for which the company may be eligible. I will now share further details on the company results, operational EBITDA and cash flow results for the first quarter. Turning to Slide 5, as we reported in our earnings release for the first quarter of 2020, we reported revenues of $267 million, compared to $291 million in the prior year quarter, for a decline of $24 million. On a constant currency basis revenue declined by $21 million. During the first quarter, volumes for SONORA Process-Free Plates grew by 18%, and the annuity revenue for PROSPER declined by 4%, which was attributable to the market downturn related to the COVID-19 pandemic. We continued to invest in future growth areas of ULTRASTREAM and advanced materials, which will lead to the new product introductions, Jim referred to earlier. On a U.S. GAAP basis, we reported a net loss of $111 million for the first quarter, compared to a net loss of $18 million in the prior year quarter. The 2020 and 2019 first quarter results include income of $53 million and expense of $1 million, respectively, related to changes in value for the derivative embedded in the Series A Preferred Stock. The first quarter of 2020 also includes the impact of a trade name impairment for $3 million, an increase in accounts receivable reserves of $4 million and $167 million non-cash expense as a result of the increase in deferred tax valuation allowances outside the U.S. Since the exact effects of COVID-19 are difficult to predict at present, it is creating a high-degree of uncertainty as to the future profitability and the individual jurisdictions around the world. As we have previously stated, the company continues to be focused on generating positive cash, by managing the company on a consolidated or One Kodak basis, and as such is making the individual jurisdictional results less certain. Therefore, the reliability of deferred tax assets outside the U.S. is also uncertain, which results in these valuation allowance establishments. Excluding these current and prior year items, income for 2020 was $10 million, compared to a loss of $17 million in the prior year quarter. Operational EBITDA for the quarter was a negative $8 million, compared to a negative $5 million in the prior year quarter. Excluding the impact of an increase in accounts receivable reserves, operational EBITDA for the current quarter was a negative $4 million, or an increase of $1 million from the prior year quarter. Entering into 2020, the company had initiated actions to reduce operating expenses by approximately $40 million for the year. These actions were expected to provide significant progress toward positive cash flow from operations for the year. However, given the uncertainty of the COVID-19 situation, we have now taken incremental cost actions and have revised their expectations to over $60 million in annualized cost reductions. Incremental cost actions were implemented early in the second quarter of 2020. We expect these impacts to start to be visible in our second quarter results. Moving on to the company cash performance presented on Slide 6. The company ended the first quarter with $209 million in cash and cash equivalents, a decrease of $24 million from December 31, 2019. Cash used in operating activities was $41 million, driven primarily by a change in working capital of $6 million, and a decrease in other liabilities of $27 million. Accounts payable increased by $1 million, inventory increased by $26 million, and accounts receivable decreased by $19 million compared to December 31, 2019. As I mentioned earlier, accounts receivable collections have slowed and inventory levels are elevated compared to our expectations. We are working closely with our customers and suppliers to manage the situation. In addition, cash used for the reduction of other liabilities includes pension payments, severance payments for restructuring actions, VAT and income tax payments and accrued interest. First quarter 2020 payments have increased, where income taxes and restructuring payments, offset by a reduction in accrued interest. Cash used in investing activities was $1 million in the first quarter as compared to a use of $3 million in the prior year period. Cash used in financing activities was $3 million in the quarter, compared to cash provided by financing activities of $3 million in the prior year period. On our last call, I indicated the company was focused on reducing restricted cash in 2020, in order to fund operations and our continued restructuring activities. In the first quarter of 2020, restricted cash was reduced by $25 million due to our efforts, which included the amendment of our ABL facility during the first quarter. Restricted cash at the end of the quarter was $32 million. We will continue to focus on alternatives to reduce restrictions on cash. Finally, as disclosed in our form 10-Q, we remain in compliance with our financial covenants under our credit agreements. Jim and I are now happy to take your questions. Jimmy, please remind listeners of instructions.